MétaCan
← all works

Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome

2017· article· en· 380 citations· W2761862301 on OpenAlex· 10.1073/pnas.1711351114

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.

No Canadian affiliation. An affiliation-only frame — the usual design — would never have seen this work. It is one of the works that make the case for inverting the frame.

Machine scores (provisional)

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Opus teacher head0.067
GPT teacher head0.351
Teacher spread
0.283 · how far apart the two teachers sit on this one work
Validation status
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Abstract

1.1. The duration and severity of thermally induced seizures and the frequency of spontaneous seizures were substantially decreased. Treatment with lower doses of CBD also improved autistic-like social interaction deficits in DS mice. Phenotypic rescue was associated with restoration of the excitability of inhibitory interneurons in the hippocampal dentate gyrus, an important area for seizure propagation. Reduced excitability of dentate granule neurons in response to strong depolarizing stimuli was also observed. The beneficial effects of CBD on inhibitory neurotransmission were mimicked and occluded by an antagonist of GPR55, suggesting that therapeutic effects of CBD are mediated through this lipid-activated G protein-coupled receptor. Our results provide critical preclinical evidence supporting treatment of epilepsy and autistic-like behaviors linked to DS with CBD. We also introduce antagonism of GPR55 as a potential therapeutic approach by illustrating its beneficial effects in DS mice. Our study provides essential preclinical evidence needed to build a sound scientific basis for increased medicinal use of CBD.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

The record

Venue
Proceedings of the National Academy of Sciences
Topic
Cannabis and Cannabinoid Research
Field
Medicine
Canadian institutions
Funders
National Institute of Neurological Disorders and StrokeEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute on Drug AbuseAlcohol and Drug Abuse Institute, University of WashingtonNational Institutes of HealthUniversity of ReadingYork UniversityGW PharmaceuticalsUniversity of WashingtonCitizens United for Research in Epilepsy
Keywords
Dravet syndromeCannabidiolEpilepsyMedicineNeurosciencePsychologyPsychiatryCannabis
Has abstract in OpenAlex
yes